Healthcare Triangle Signs Letter of Intent to Pursue the Proposed Acquisition of Roboticom's Cutting-Edge Industrial Precision Robotics Automation Business

Healthcare Triangle, Inc. (Nasdaq: HCTI ) ("HCTI" or the "Company") today announced it has signed a non-binding Letter of Intent ("LOI") with Crestpoint Capital LLC ("Seller") outlining a proposed transaction in which HCTI would acquire certain intellectual property, trademarks and business assets associated with Roboticom (roboticom.it), a Pisa, Italy-based provider of industrial robotic automation systems for precision surface treatment, marketed under the SandRob™, ORTIS™ and ScultoRob™ product lines and serving aerospace, marine, composites, orthotics and prosthetics, and industrial-tooling customers.

HCTI believes that, if consummated, the proposed acquisition could potentially extend the Company's technology platform beyond healthcare into industrial automation and advanced manufacturing — sectors the Company believes are experiencing significant growth driven in part by AI adoption — while creating an opportunity to combine HCTI's existing artificial intelligence, cloud and data capabilities with Roboticom's established industrial robotics platform.

Roboticom's technology is marketed through its SandRob™, ORTIS™ and ScultoRob™ product lines and serves applications across aerospace, marine, composites, orthotics and prosthetics, automotive, advanced manufacturing and industrial tooling.

Based on unaudited financial information provided by Roboticom's current ownership group, the business generated approximately $14.1 million in revenue and $6.9 million in gross margin and was EBITDA-positive for fiscal year 2025.

Roboticom management's five-year forward-looking projections target $153.5 million in revenue and $64 million in adjusted operating contribution by fiscal year 2029/30; the projections were provided by Roboticom management, are unaudited and unverified by HCTI, subject to significant uncertainty, and actual results may differ materially.

"Adjusted operating contribution" is a non-GAAP financial measure that has not been reconciled to the most directly comparable GAAP measure and may not be comparable to similarly titled measures used by other companies. HCTI is not adopting or endorsing these projections, and investors should not place undue reliance on them. The projections are unaudited, have not been independently verified by HCTI, and remain subject to significant assumptions, uncertainties and confirmation through due diligence, actual results may differ materially.

Under the terms outlined in the LOI, HCTI would acquire 100% of the customer contracts, identified intellectual property, trademarks and business assets for total consideration of up to $30 million in cash and equity paid over time.

"I believe this could represent a significant opportunity for HCTI. I am pleased to explore entering the robotics space and the prospect of combining our AI technology with this business to enhance its competitive positioning." — David Ayanoglou, Chief Financial Officer, Healthcare Triangle, Inc.

According to publicly available information, Roboticom is a brand of Fabrica Machinale Srl, an Epica International company, based in Navacchio di Cascina (Pisa), Italy, with a commercial presence in Landrum, South Carolina. Its robotic automation systems — including the SandRob™, ORTIS™ and ScultoRob™ product lines and ARPP® software — serve aerospace, automotive, solid-surface, orthopedics, sanitary ware, art and design, woodworking and foundry customers.

HCTI's due diligence will include confirmation of the Seller's title to the assets described in the LOI.